Board of Directors

Officers

  • President

    Julie M. Vose, MD, MBA, FASCO

    University of Nebraska Medical Center and Fred and Pamela Buffett Cancer Center
    Board Term: 2015-2016
    Speciality: Oncology/Hematology

    Julie M. Vose, MD, MBA, FASCO, is the Neumann M. and Mildred E. Harris Professorial Chair and Chief of the Oncology/Hematology Division in the Department of Internal Medicine at the University of Nebraska Medical Center (UNMC). She is also the Associate Director of Clinical Research at the Fred and Pamela Buffett Cancer Center.

    Bio
  • President-Elect

    Daniel F. Hayes, MD, FASCO

    University of Michigan Comprehensive Cancer Center
    Board Term: 2015-2016
    Specialty: Breast Cancer

    Daniel F. Hayes, MD, FASCO, is a Professor of Internal Medicine, the Stuart B. Padnos Professor in Breast Cancer, and the Clinical Director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center. He is a breast cancer specialist.

    Bio
  • Past-President

    Peter Paul Yu, MD, FACP, FASCO

    Palo Alto Medical Foundation
    Board Term: 2015-2016
    Specialty: Medical Oncology / Hematology

    Peter Paul Yu, MD, FACP, FASCO, is a medical oncologist and hematologist and Director of Cancer Research at Palo Alto Medical Foundation, where he has worked since 1989. In addition to his role as Immediate Past President, Dr. Yu also serves on the Scientific Program, Nominating, Government Relations, and Special Awards Selection Committees.

    Bio
  • Treasurer

    Craig R. Nichols, MD

    Virginia Mason Medical Center
    Board Term: 2015-2018
    Specialty: Testicular Cancer

    Craig R. Nichols, MD, is the Co-Director of the Testicular Cancer Multidisciplinary Clinic at Virginia Mason Medical Center in Seattle. He serves as co-primary investigator on the recently funded Northwest National Cancer Institute Community Oncology Research Program. Dr. Nichols is the Executive Officer of Cancer Control and Prevention Research for the Southwest Oncology Group (SWOG). His clinical expertise is in testicular cancer.

    Bio
  • ASCO CEO and CCF CEO (ex-officio)

    Allen S. Lichter, MD, FASCO

    Board Term: 2006-2016
    Specialty: Radiation Oncology

    Allen S. Lichter, MD, FASCO, is the Chief Executive Officer of the American Society of Clinical Oncology and the Conquer Cancer Foundation of ASCO. He has been an ASCO member since 1980 and served the Society in an array of volunteer capacities before accepting the position of CEO in 2006. Dr. Lichter’s research and development of three-dimensional treatment planning led to a Gold Medal from the American Society for Radiation Oncology. In 2002, he was elected to membership in the Institute of Medicine of the National Academies of Science.

    Bio

Board Members

  • Smita Bhatia, MD, MPH

    University of Alabama at Birmingham School of Medicine
    Board Term: 2012-2016
    Board Seat: Pediatric Oncologist

  • Charles D. Blanke, MD, FACP, FASCO

    Oregon Health & Science University's Knight Cancer Institute
    Board Term: 2014-2018
    Board Seat: Undesignated Specialty

  • Linda D. Bosserman, MD, FACP

    City of Hope
    Board Term: 2014-2018
    Board Seat: Community Oncologist

  • Walter J. Curran, Jr., MD, FACR

    Winship Cancer Institute of Emory University
    Board Term: 2014-2018
    Board Seat: Radiation Oncologist
     

  • Stephen B. Edge, MD, FACS, FASCO

    Baptist Cancer Center
    Board Term: 2015-2019
    Board Seat: Undesignated Specialty

  • Paulo M. G. Hoff, MD, PhD, FACP

    ICESP—Instituto do Câncer do Estado de São Paulo
    Board Term: 2013-2017
    Board Seat: Undesignated Specialty

  • Hagop M. Kantarjian, MD

    University of Texas MD Anderson Cancer Center
    Board Term: 2012-2016
    Board Seat: Undesignated Specialty

  • David Khayat, MD, PhD, FASCO

    Pitié-Salpêtrière Hospital
    Board Term: 2014-2018
    Board Seat: International Oncologist

  • Gary H. Lyman, MD, MPH, FACP, FRCP (Edin), FASCO

    Hutchinson Institute for Cancer Outcomes Research
    Board Term: 2012-2016
    Board Seat: Undesignated Specialty

  • Neal J. Meropol, MD, FASCO

    University Hospitals Case Medical Center & Case Western Reserve University
    Board Term: 2013-2017
    Board Seat: Medical Oncologist

  • Therese M. Mulvey, MD, FASCO

    Southcoast Centers for Cancer Care
    Board Term: 2013-2017
    Board Seat: Community Oncologist

  • J. Chris Nunnink, MD, FASCO

    Fletcher Allen Health Care
    Board Term: 2015-2019
    Board Seat: Community Oncologist

  • W. Charles Penley, MD, FASCO

    Tennessee Oncology, PLLC
    Board Term: 2013-2017
    Board Seat: Conquer Cancer Foundation

  • Lillian L. Siu, MD, FRCPC

    Princess Margaret Hospital/University of Toronto
    Board Term: 2012-2016
    Board Seat: International Oncologist

  • Jedd D. Wolchok, MD, PhD

    Memorial Sloan Kettering Cancer Center
    Board Term: 2015-2019
    Board Seat: Undesignated Specialty